News & Events

Press Releases

Arlington, VA—Management Sciences for Health (MSH) welcomes President Biden’s announcement that the United States will contribute $4 billion to COVAX, an international effort to source and distribute COVID-19 vaccines. An initial $2 billion will be donated in 2021, with an additional $2 billion coming over the next two years.“This U.S. pledge, along with that of a number of other countries, will go a long way in ending the current pandemic and helping to prevent future ones,” said MSH’s Senior External Affairs Officer, Ashley Arabasadi.


The black market for COVID vaccines and proof of vaccination is growing rapidly as people tire of restrictions and are anxious to return to normalcy. It is also driven by the inequitable distribution of vaccines, leaving many low- and middle-income (LMIC) countries behind.Many of the dangers are obvious—a person may become more ill or die because of receiving an ineffective medicine for their illness. Less obvious is that counterfeit antibiotics can promote antibiotic resistance and fuel the spread of drug resistant organisms throughout communities.Fake vaccines—substituting plain salt water for a vaccine, for example—might not cause immediate harm, but may fuel distrust about vaccines’ effectiveness. People will falsely assume that they are protected and engage in risky behaviors.One of the problems with these scams is that they not only hurt individuals, but they hurt all of us. Until we get widespread vaccine uptake and herd immunity, we will not stop the spread of coronavirus, and mutant strains will proliferate.


February 24, 2021

On February 24th, the Global Digital Health Network invited MSH to host a webinar discussion focused on Digital Tools for Pharmaceutical Systems. Visit the event page Pharmaceutical systems depend on efficient and reliable information tools, data governance, and data analytics systems to ensure sustainable access to and appropriate use of safe, effective, quality assured, and affordable products and services. Many low- and middle-income countries (LMICs), however, suffer from poor data availability and accessibility.